BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20976000)

  • 21. Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya.
    Huchko MJ; Leslie H; Sneden J; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
    Int J Cancer; 2014 Feb; 134(3):740-5. PubMed ID: 23900762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV Types in Cervical Precancer by HIV Status and Birth Region: A Population-Based Register Study.
    Carlander C; Lagheden C; Eklund C; Nordqvist Kleppe S; Dzabic M; Wagner P; Yilmaz A; Elfgren K; Sönnerborg A; Sparén P; Dillner J
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2662-2668. PubMed ID: 32967862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precancerous Cervical Lesion Among HIV-Positive Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
    Weldegebreal F; Worku T
    Cancer Control; 2019; 26(1):1073274819845872. PubMed ID: 31043067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte Subsets in Cervicovaginal Lavage Specimens of HIV-Infected Women: A Surrogate Risk Marker of HPV-Associated Cervical Lesions.
    Brito MJ; Quintas A; Passos F; Alves AT; Félix A; Martins CG
    Pathobiology; 2023; 90(3):176-186. PubMed ID: 36302344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study.
    Odida M; Sandin S; Mirembe F; Kleter B; Quint W; Weiderpass E
    Infect Agent Cancer; 2011 Jun; 6(1):8. PubMed ID: 21702999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.
    Abraham AG; D'Souza G; Jing Y; Gange SJ; Sterling TR; Silverberg MJ; Saag MS; Rourke SB; Rachlis A; Napravnik S; Moore RD; Klein MB; Kitahata MM; Kirk GD; Hogg RS; Hessol NA; Goedert JJ; Gill MJ; Gebo KA; Eron JJ; Engels EA; Dubrow R; Crane HM; Brooks JT; Bosch RJ; Strickler HD;
    J Acquir Immune Defic Syndr; 2013 Apr; 62(4):405-13. PubMed ID: 23254153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and progression of cervical lesions in women with HIV: a systematic global review.
    Denslow SA; Rositch AF; Firnhaber C; Ting J; Smith JS
    Int J STD AIDS; 2014 Mar; 25(3):163-77. PubMed ID: 24216030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precancerous cervical lesion and associated factors among HIV-infected women in Ethiopia: systematic review and meta- analysis.
    Ferede YA; Tassew WC; Zeleke AM
    BMC Cancer; 2024 Jun; 24(1):678. PubMed ID: 38831404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trend of HPV 16/18 Genotypes in Cervical Intraepithelial Neoplasia Grade 3: Data for 2007-2018.
    Giannella L; Delli Carpini G; Di Giuseppe J; Bogani G; Gardella B; Monti E; Liverani CA; Ghelardi A; Insinga S; Montanari M; Raspagliesi F; Spinillo A; Vercellini P; Roncella E; Ciavattini A
    Infect Drug Resist; 2021; 14():3763-3771. PubMed ID: 34557001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Over-reported peripheral neuropathy symptoms in a cohort of HIV infected and uninfected Rwandan women: the need for validated locally appropriate questionnaires.
    Tumusiime DK; Musabeyezu E; Mutimurah E; Hoover DR; Shi Q; Rudakemwa E; Ndacyayisenga V; Dusingize JC; Sinayobye JD; Stewart A; Venter FW; Anastos K
    Afr Health Sci; 2014 Jun; 14(2):460-7. PubMed ID: 25320598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the Proteome in the Development of Chronic Human Papillomavirus Infection-A Prospective Study in HIV Positive and HIV Negative Rwandan Women.
    Bienvenu E; Mukanyangezi MF; Rulisa S; Martner A; Hasséus B; Vorontsov E; Tobin G; Giglio D
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting.
    Glasmeyer L; Mcharo RD; Torres L; Lennemann T; Danstan E; Mwinuka N; Judick M; Mueller W; Mbuya W; Hölscher M; Lellé R; Geldmacher C; Kroidl A; France JR
    BMC Cancer; 2022 Aug; 22(1):892. PubMed ID: 35971100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV serostatus and tumor differentiation among patients with cervical cancer at Bugando Medical Centre.
    Matovelo D; Magoma M; Rambau P; Massinde A; Masalu N
    BMC Res Notes; 2012 Aug; 5():406. PubMed ID: 22862747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and genotypes of human papilloma virus infection in CIN3 in Beijing, China.
    Zhao XY; Kong WM; Jiao SM; Song D; Chen J; Shang RT
    Transl Cancer Res; 2020 Mar; 9(3):1978-1984. PubMed ID: 35117544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibited interpersonal coping style predicts poorer adherence to scheduled clinic visits in human immunodeficiency virus infected women at risk for cervical cancer.
    Pereira DB; Antoni MH; Danielson A; Simon T; Efantis-Potter J; O'Sullivan MJ
    Ann Behav Med; 2004 Dec; 28(3):195-202. PubMed ID: 15576258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of haematological parameters in HIV-infected and uninfected Rwandan women: a cross-sectional study.
    Munyazesa E; Emile I; Mutimura E; Hoover DR; Shi Q; McGinn AP; Musiime S; Muhairwe F; Rutagengwa A; Dusingize JC; Anastos K
    BMJ Open; 2012; 2(6):. PubMed ID: 23169875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer.
    Zuna RE; Tuller E; Wentzensen N; Mathews C; Allen RA; Shanesmith R; Dunn ST; Gold MA; Wang SS; Walker J; Schiffman M
    Infect Agent Cancer; 2011 Oct; 6():19. PubMed ID: 22035468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasive cervical cancer risk among HIV-infected women is a function of CD4 count and screening.
    Abraham AG; Strickler HD; D'Souza G
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):e163. PubMed ID: 24135779
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens.
    Giorgi C; Di Bonito P; Grasso F; Mochi S; Accardi L; Donà MG; Branca M; Costa S; Mariani L; Agarossi A; Ciotti M; Syrjänen K;
    Infect Agent Cancer; 2008 Jun; 3():9. PubMed ID: 18582363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stress Management, Depression and Immune Status in Lower Income Racial/Ethnic Minority Women Co-infected with HIV and HPV.
    Lopez CR; Antoni MH; Pereira D; Seay J; Whitehead N; Potter J; O'Sullivan M; Fletcher MA
    J Appl Biobehav Res; 2013 Mar; 18(1):37-57. PubMed ID: 23526866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.